Related Experiment Video
Updated: Mar 13, 2026
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
41.7K
Effectiveness of Inhalant Abuse Legislation
1a Psychology , Indiana University Kokomo , Kokomo , Indiana , USA.
Substance Use & Misuse
|October 19, 2016
Summary
Anti-inhalant abuse legislation has not demonstrably reduced self-reported rates of inhalant use in adolescents. Despite widespread laws, the decline in inhalant abuse appears unrelated to legislative efforts, suggesting a need for further research and potentially amended policies.
Area of Science:
- Public Health
- Criminology
- Sociology
Background:
- Inhalant abuse rates have declined significantly since the 1990s.
- Most U.S. states have enacted legislation to combat inhalant abuse.
- Historical sex differences in inhalant abuse are no longer apparent.
Purpose of the Study:
- To assess the impact of anti-inhalant abuse legislation on self-reported inhalant use among high school-aged males and females.
Main Methods:
- Utilized data from the CDC's Youth Risk Behavior Surveillance Survey (YRBS) from 1993 onwards.
- Collected data on the enactment dates of anti-inhalant abuse laws in 46 states.
- Employed Analysis of Variance (ANOVA) to analyze the relationship between legislation and inhalant abuse rates.
Main Results:
- No significant effects or interactions were found, indicating that inhalant abuse rates did not decrease in response to legislation.
- The observed decline in inhalant abuse over two decades shows no correlation with the passage of state-level laws.
Conclusions:
- Current anti-inhalant abuse legislation has not proven effective in reducing self-reported use.
- The decrease in inhalant abuse is likely attributable to factors other than legislation.
- Future research should explore the causes of declining inhalant abuse and consider legislative amendments to include treatment options.
More Related Videos
Related Concept Videos
01:23Inhaled Medications
952
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
952
01:20Inhalational Anesthetics: Overview
1.4K
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.4K
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
1.5K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
1.5K
01:30Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
01:18Additional Routes of Drug Administration
5.3K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
5.3K
01:28Adrenergic Agonists: Mixed-Action Agents
1.7K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.7K